Does ALK-ABELLO A/S SHARES -B- DENMARK (OTCMKTS:AKBLF) Have Gas After Even More Sellers Involved?

June 17, 2018 - By Peter Erickson

ALK-Abelló A/S (OTCMKTS:AKBLF) Logo

The stock of ALK-ABELLO A/S SHARES -B- DENMARK (OTCMKTS:AKBLF) registered an increase of 1.84% in short interest. AKBLF’s total short interest was 177,300 shares in June as published by FINRA. Its up 1.84% from 174,100 shares, reported previously.

It closed at $159.4134 lastly. It is down 0.00% since June 17, 2017 and is . It has underperformed by 12.57% the S&P500.

ALK-Abelló A/S, a pharmaceutical company, develops, makes, and sells a range of products for the diagnosis and treatment of respiratory diseases and allergic asthma worldwide. The company has market cap of $1.86 billion. The firm offers allergy immunotherapy products, such as subcutaneous injections, sublingual droplets, and sublingual tablets. It currently has negative earnings. The Company’s allergy immunotherapy products are used for treating various allergies, including grass, ragweed, house dust mite, tree, Japanese cedar, cat, dog, and venom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.